Bill Holdings, Inc. (BILL) Stock Price & Analysis

Bill Holdings, Inc. (BILL) fell 2.99% to USD 34.09 as of June 10, 2026 at 00:54 UTC, according to Nexqual real-time market data.

BILL last closed at USD 35.14; the session ranged USD 33.29–35.33 on volume of 2,685,981 shares. Market capitalization is $3.40B, with a 52-week range of USD 33.29–57.21 (NYQ). Source: Nexqual, June 10, 2026 at 00:54 UTC.

Key Statistics (as of June 10, 2026 at 00:54 UTC)

PriceUSD 34.09
Change▼ 2.99% (down)
Previous CloseUSD 35.14
OpenUSD 34.69
Day RangeUSD 33.29 – 35.33
52-Week RangeUSD 33.29 – 57.21
Volume2,685,981 shares
Market Cap$3.40B
ExchangeNYQ

Technical Analysis (BILL)

Nexqual's technical model rates BILL "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:54 UTC.

Overall SignalSELL
RSI (14)38.62 (neutral)
vs SMA50Below (USD 37.82)
MACD-0.91 (negative)

Analyst Ratings (BILL)

Wall Street analysts rate BILL "Buy" based on 21 analysts, with a mean price target of USD 54.62 (range USD 42–77), per Nexqual as of June 10, 2026 at 00:54 UTC.

Consensus RatingBuy
Analyst Count21
Mean TargetUSD 54.62
High TargetUSD 77
Low TargetUSD 42
Buy / Hold / Sell14 / 9 / 0

Earnings (BILL)

Next Earnings Date2026-05-07
EPS EstimateUSD 0.7
Revenue Estimate$430.52M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD 0.68 vs est 0.55 ▲ beat
2025-12-31USD 0.64 vs est 0.56 ▲ beat
2025-09-30USD 0.61 vs est 0.51 ▲ beat
2025-06-30USD 0.53 vs est 0.41 ▲ beat

Source: Nexqual, June 10, 2026 at 00:54 UTC.

Financials & Fundamentals (BILL)

Total Revenue$1.60B
Revenue Growth (YoY)+13.50%
Gross Margin+83.68%
Operating Margin+1.14%
Profit Margin+0.01%
ROE+0.00%
Debt / Equity49.59
Current Ratio1.66
Total Cash$2.17B
Total Debt$1.89B
Free Cash Flow$167.61M

Source: Nexqual, June 10, 2026 at 00:54 UTC.

Financial Health Score (BILL)

Nexqual rates Bill Holdings, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:54 UTC.

GrowthSolid — Revenue +13% YoY (annual)
ProfitabilityStrong — Gross margin 84%, operating 1%
Balance SheetSolid — $2.17B cash vs $1.89B debt, net cash position
Cash FlowSolid — FCF $168M, 11% margin
EfficiencyWeak — ROE 0%, ROA -0.3%

Ownership (BILL)

Insider Ownership+12.33%
Institutional Ownership+104.62%
Shares Outstanding99.60M
Float88.87M
Short % of Float+16.95%

Source: Nexqual, June 10, 2026 at 00:54 UTC.

Leadership (BILL)

Bill Holdings, Inc. is led by Rene A. Lacerte (age 57), Founder, CEO & Chairperson of the Board, per Nexqual as of June 10, 2026 at 00:54 UTC.

Founder, CEO & Chairperson of the BoardRene A. Lacerte (age 57)
Chief Technology OfficerKenneth Moss (age 59)
Chief Strategy & Transformation OfficerJohn R. Rettig (age 59)
Chief Product OfficerMike Cieri (age 45)
Chief Financial Officer & Principal Accounting OfficerRohini Jain (age 45)

Major Backers & Investors (BILL)

Notable institutional backers of Bill Holdings, Inc. include ER Collective Holdings, LLC, Starboard Value LP, Wellington Management, according to Nexqual as of June 10, 2026 at 00:54 UTC.

Active Investors

InvestorStake
ER Collective Holdings, LLC8.55%
Starboard Value LP7.05%
Wellington Management3.88%
Senvest Management LLC3.85%
Contour Asset Management LLC3.36%
Greenhouse Funds, LLLP3.2%

Index Funds (Passive)

FundStake
Vanguard Group18.82%
BlackRock11.37%
State Street3.11%
Columbia Threadneedle1.55%

Source: Nexqual, June 10, 2026 at 00:54 UTC.

From Bill Holdings, Inc.'s Latest SEC 10-K Filing (filed 2025-08-28)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
GTMZoomInfo Technologies Inc.USD 2.77▼ 7.05%
ESTCElastic N.V.USD 61.26▼ 0.86%
ASANAsana, Inc.USD 7.54▼ 3.83%
HUBSHubSpot, Inc.USD 197.69▼ 7.03%
MNDYmonday.com Ltd.USD 83.23▼ 2.93%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:54 UTC. This page is informational and not investment advice.